Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Annette Juul Vangsted
Sign up to set email alerts
275
Publications
3,201
Citation Statements Received
7,188
Citation Statements Given
How they've been cited
5,187
121
3,055
25
How they cite others
7,002
323
6,790
75
Affiliations
Rigshospitalet
,
University of Copenhagen
Publications
Order By: Most citations
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Sonneveld
1
,
Dimopoulos
2
,
Boccadoro
3
et al.
2024
N Engl J Med
625
4
256
0
Get access via publisher
Add to collection
Cite
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Moreau
1
,
Kumar
2
,
San Miguel
3
et al.
2021
The Lancet Oncology
290
2
240
0
Get access via publisher
Add to collection
Cite
Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
Mitchell
1
,
Ni
2
,
Weinhold
3
et al.
2016
Nat Commun
Abstract
Show
193
4
185
0
Get access via publisher
Add to collection
Cite
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)
Terpos
1
,
Engelhardt
2
,
Cook
3
et al.
2020
Leukemia
Abstract
Show
154
1
181
0
Get access via publisher
Add to collection
Cite
Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma
Brimnes
1
,
Vangsted
2
,
Knudsen
3
et al.
2010
Abstract
Show
219
9
159
2
Get access via publisher
Add to collection
Cite
Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma
Swaminathan
1
,
Þorleifsson
2
,
Jöud
3
et al.
2015
Nat Commun
Abstract
Show
1,216
10
108
0
Get access via publisher
Add to collection
Cite
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
Went
1
,
Sud
2
,
Försti
3
et al.
2018
Nat Commun
Abstract
Show
119
7
105
0
2
Get access via publisher
Add to collection
Cite
Causes of early death in multiple myeloma patients who are ineligible for high‐dose therapy with hematopoietic stem cell support: A study based on the nationwide
D
anish
M
yeloma
D
atabase
Holmström
1
,
Gimsing
2
,
Abildgaard
3
et al.
2015
American J Hematol
Abstract
Show
66
3
76
0
Get access via publisher
Add to collection
Cite
1
2
3